Page 7 - Counter Analysis System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NanoString Technologies (NASDAQ:NSTG – Get Free Report) and Nephros (NASDAQ:NEPH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends. Insider & Institutional Ownership 94.1% of NanoString Technologies […]

Stock analysts at StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. NSTG has been the topic of several other reports. Morgan Stanley dropped their price target on NanoString […]

NanoString Technologies (NASDAQ:NSTG – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.70) by ($0.22), Briefing.com reports. The firm had revenue of $44.16 million during the quarter, compared to analyst estimates of $42.45 million. NanoString Technologies had […]

Granite Investment Partners LLC grew its stake in shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Free Report) by 5.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 307,334 shares of the biotechnology company’s stock after acquiring an additional 15,516 shares during the […]

Shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year […]